JP2017505785A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017505785A5 JP2017505785A5 JP2016550869A JP2016550869A JP2017505785A5 JP 2017505785 A5 JP2017505785 A5 JP 2017505785A5 JP 2016550869 A JP2016550869 A JP 2016550869A JP 2016550869 A JP2016550869 A JP 2016550869A JP 2017505785 A5 JP2017505785 A5 JP 2017505785A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- hydroxy
- derivative
- optionally substituted
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 13
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 9
- 150000001875 compounds Chemical class 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 3
- 208000010706 fatty liver disease Diseases 0.000 claims 3
- 239000001301 oxygen Substances 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- 125000002252 acyl group Chemical group 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims 2
- 125000004429 atom Chemical group 0.000 claims 2
- 229910021386 carbon form Inorganic materials 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- RXZBMPWDPOLZGW-XMRMVWPWSA-N (E)-roxithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=N/OCOCCOC)/[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 RXZBMPWDPOLZGW-XMRMVWPWSA-N 0.000 claims 1
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical compound N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 150000007854 aminals Chemical class 0.000 claims 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 claims 1
- 229960004099 azithromycin Drugs 0.000 claims 1
- 150000001721 carbon Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 229960004100 dirithromycin Drugs 0.000 claims 1
- WLOHNSSYAXHWNR-NXPDYKKBSA-N dirithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H]2O[C@H](COCCOC)N[C@H]([C@@H]2C)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 WLOHNSSYAXHWNR-NXPDYKKBSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 150000002084 enol ethers Chemical class 0.000 claims 1
- XOEUHCONYHZURQ-HNUBZJOYSA-N flurithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@@](C)(F)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 XOEUHCONYHZURQ-HNUBZJOYSA-N 0.000 claims 1
- 229960001398 flurithromycin Drugs 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 229960005224 roxithromycin Drugs 0.000 claims 1
- 125000000547 substituted alkyl group Chemical group 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461939961P | 2014-02-14 | 2014-02-14 | |
| US61/939,961 | 2014-02-14 | ||
| US201461984225P | 2014-04-25 | 2014-04-25 | |
| US61/984,225 | 2014-04-25 | ||
| US201462086911P | 2014-12-03 | 2014-12-03 | |
| US62/086,911 | 2014-12-03 | ||
| PCT/US2015/015353 WO2015123256A1 (en) | 2014-02-14 | 2015-02-11 | Compositions and methods for treating diabetes and liver diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019124815A Division JP2019189639A (ja) | 2014-02-14 | 2019-07-03 | 糖尿病および肝疾患を治療するための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017505785A JP2017505785A (ja) | 2017-02-23 |
| JP2017505785A5 true JP2017505785A5 (enExample) | 2018-03-22 |
| JP6553067B2 JP6553067B2 (ja) | 2019-07-31 |
Family
ID=53800574
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016550869A Active JP6553067B2 (ja) | 2014-02-14 | 2015-02-11 | 糖尿病および肝疾患を治療するための組成物および方法 |
| JP2019124815A Pending JP2019189639A (ja) | 2014-02-14 | 2019-07-03 | 糖尿病および肝疾患を治療するための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019124815A Pending JP2019189639A (ja) | 2014-02-14 | 2019-07-03 | 糖尿病および肝疾患を治療するための組成物および方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20170165286A1 (enExample) |
| EP (1) | EP3105234A4 (enExample) |
| JP (2) | JP6553067B2 (enExample) |
| KR (1) | KR20160113307A (enExample) |
| CN (1) | CN106132969A (enExample) |
| AU (1) | AU2015217293A1 (enExample) |
| CA (1) | CA2939076A1 (enExample) |
| IL (1) | IL247152A0 (enExample) |
| MX (1) | MX2016010447A (enExample) |
| RU (1) | RU2016133471A (enExample) |
| WO (1) | WO2015123256A1 (enExample) |
| ZA (1) | ZA201606199B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008316830B2 (en) | 2007-10-25 | 2016-03-17 | Cempra Pharmaceuticals, Inc. | Process for the preparation of macrolide antibacterial agents |
| CN107854477A (zh) | 2008-10-24 | 2018-03-30 | 森普拉制药公司 | 使用含三唑的大环内酯治疗抗性疾病的方法 |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| WO2013148891A1 (en) | 2012-03-27 | 2013-10-03 | Cempra Pharmaceuticals, Inc. | Parenteral formulations for administering macrolide antibiotics |
| ES2795450T3 (es) | 2012-09-17 | 2020-11-23 | Madrigal Pharmaceuticals Inc | Procedimiento para sintetizar análogos de hormonas tiroideas y polimorfos de los mismos |
| WO2014152326A1 (en) | 2013-03-14 | 2014-09-25 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
| MX394463B (es) | 2016-10-18 | 2025-03-19 | Madrigal Pharmaceuticals Inc | Métodos para tratar trastornos del hígado o trastornos lipídicos con un agonista de thr-beta. |
| WO2018094265A2 (en) * | 2016-11-21 | 2018-05-24 | Viking Therapeutics, Inc. | Method of treating glycogen storage disease |
| JP2024044227A (ja) * | 2022-09-20 | 2024-04-02 | 国立大学法人岩手大学 | グルコース産生抑制剤 |
| US12377104B1 (en) | 2024-02-06 | 2025-08-05 | Madrigal Pharmaceuticals, Inc. | Methods for treating a fatty liver disease |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5760010A (en) * | 1995-01-01 | 1998-06-02 | Klein; Ira | Method of treating liver disorders with a macrolide antibiotic |
| CA2292359C (en) * | 1999-01-28 | 2004-09-28 | Pfizer Products Inc. | Novel azalides and methods of making same |
| FR2897154B1 (fr) * | 2006-02-08 | 2008-03-07 | Airbus France Sas | Dispositif pour construire et securiser une trajectoire de vol a basse altitude destinee a etre suivie par un aeronef. |
| JP5126685B2 (ja) * | 2006-05-01 | 2013-01-23 | 大正製薬株式会社 | マクロライド誘導体 |
| JP5025249B2 (ja) * | 2006-12-15 | 2012-09-12 | Ｎｓｋワーナー株式会社 | 発進クラッチ |
| JP5150740B2 (ja) * | 2011-01-21 | 2013-02-27 | 株式会社小松製作所 | 作業車両 |
| CN103649088B (zh) * | 2011-08-30 | 2016-05-11 | 沃克哈特有限公司 | 1, 6- 二氮杂双环[3, 2, 1]辛- 7- 酮衍生物及其在治疗细菌感染中的用途 |
| US9078975B2 (en) * | 2011-09-30 | 2015-07-14 | Becton Dickinson France, S.A.S. | Syringe having pivoting arm plunger rod |
-
2015
- 2015-02-11 WO PCT/US2015/015353 patent/WO2015123256A1/en not_active Ceased
- 2015-02-11 US US15/118,124 patent/US20170165286A1/en not_active Abandoned
- 2015-02-11 JP JP2016550869A patent/JP6553067B2/ja active Active
- 2015-02-11 MX MX2016010447A patent/MX2016010447A/es unknown
- 2015-02-11 AU AU2015217293A patent/AU2015217293A1/en not_active Abandoned
- 2015-02-11 KR KR1020167025193A patent/KR20160113307A/ko not_active Ceased
- 2015-02-11 RU RU2016133471A patent/RU2016133471A/ru not_active Application Discontinuation
- 2015-02-11 CN CN201580015346.1A patent/CN106132969A/zh active Pending
- 2015-02-11 EP EP15749185.3A patent/EP3105234A4/en not_active Withdrawn
- 2015-02-11 CA CA2939076A patent/CA2939076A1/en not_active Abandoned
-
2016
- 2016-08-07 IL IL247152A patent/IL247152A0/en unknown
- 2016-09-07 ZA ZA2016/06199A patent/ZA201606199B/en unknown
-
2019
- 2019-07-03 JP JP2019124815A patent/JP2019189639A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012506872A5 (enExample) | ||
| RU2016133471A (ru) | Композиции и способы для лечения диабета и заболеваний печени | |
| JP2017526677A5 (enExample) | ||
| JP2014510729A5 (enExample) | ||
| JP2016515561A5 (enExample) | ||
| RU2015149527A (ru) | Производные доластатина 10 и ауристатинов | |
| JP2014500861A5 (enExample) | ||
| JP2013518107A5 (enExample) | ||
| JP2013542261A5 (enExample) | ||
| JP2016516043A5 (enExample) | ||
| JP2015508103A5 (enExample) | ||
| JP2016503793A5 (enExample) | ||
| JP2010077141A5 (enExample) | ||
| JP2019516713A5 (enExample) | ||
| JP2018507914A5 (enExample) | ||
| JP2017531619A5 (enExample) | ||
| JP2014528464A5 (enExample) | ||
| JP2016503052A5 (enExample) | ||
| JP2011527299A5 (enExample) | ||
| JP2012506870A5 (enExample) | ||
| JP2017517565A5 (enExample) | ||
| JP2017514910A5 (enExample) | ||
| JP2016513696A5 (enExample) | ||
| JP2016531126A5 (enExample) | ||
| JP2017503833A5 (enExample) |